XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.healtheconomics.com/government/khns-hancock-hangups-abound-in-efforts-to-cut-drug-prices60%Hourly2017-09-29 16:58
https://www.healtheconomics.com/industry-news/american-society-of-health-economists-meeting-slated60%Hourly2017-09-29 16:09
https://www.healtheconomics.com/comparative-effectiveness/biopharma-companies-pledge-500000-to-pais-hero360%Hourly2017-09-29 15:34
https://www.healtheconomics.com/industry-news/npc-precision-health-economics-release-study-on-pharma-costs60%Hourly2017-09-29 14:52
https://www.healtheconomics.com/featured-2/umd-school-of-pharmacy-offers-course-on-healthcare-quality60%Hourly2017-09-29 14:27
https://www.healtheconomics.com/industry-news/robert-wood-johnson-foundation-issues-call-for-proposals60%Hourly2017-09-28 17:06
https://www.healtheconomics.com/government/dems-multiple-sclerosis-activists-target-high-drug-prices60%Hourly2017-09-28 16:28
https://www.healtheconomics.com/industry-news/hesitancy-among-physicians-amid-shift-toward-value60%Hourly2017-09-28 16:05
https://www.healtheconomics.com/comparative-effectiveness/health-affairs-blog-rwe-a-welcome-addition-to-randomized-controlled-trials60%Hourly2017-09-28 15:25
https://www.healtheconomics.com/government/biotech-vets-discuss-drug-approvals-under-gottlieb60%Hourly2017-09-28 14:52
https://www.healtheconomics.com/comparative-effectiveness/eyeforpharma-spotlights-data-pragmatic-trials-in-interview60%Hourly2017-09-27 16:17
https://www.healtheconomics.com/comparative-effectiveness/outcomes-based-pricing-for-pcsk9-inhibitors60%Hourly2017-09-27 15:45
https://www.healtheconomics.com/government/graham-cassidy-health-bill-dies-without-vote60%Hourly2017-09-27 15:06
https://www.healtheconomics.com/comparative-effectiveness/fda-urges-stronger-clinical-research60%Hourly2017-09-27 14:31
https://www.healtheconomics.com/government/trump-order-may-encourage-outcomes-based-contracts60%Hourly2017-09-27 14:02
https://www.healtheconomics.com/industry-news/pri-senior-fellow-pharma-pricing-process-convoluted-detrimental60%Hourly2017-09-25 16:45
https://www.healtheconomics.com/government/new-graham-cassidy-draft-includes-big-changes60%Hourly2017-09-26 17:13
https://www.healtheconomics.com/government/ajmcs-this-week-in-managed-care-cms-eyes-innovation-center-overhaul-aca-repeal60%Hourly2017-09-26 14:51
https://www.healtheconomics.com/industry-news/challenges-ahead-for-new-pharma-ceos60%Hourly2017-09-25 16:25
https://www.healtheconomics.com/industry-news/graphic-7-biosimilars-okd-by-fda60%Hourly2017-09-25 16:08
https://www.healtheconomics.com/government/ex-cms-communications-director-trumps-cuts-could-ruin-health-care-law60%Hourly2017-09-25 15:59
https://www.healtheconomics.com/government/jeb-bush-the-graham-cassidy-proposal-is-better-than-kasich-hickenlooper60%Hourly2017-09-25 15:37
https://www.healtheconomics.com/uncategorized/uncertainty-ahead-with-icer-va-agreement60%Hourly2017-09-25 14:51
https://www.healtheconomics.com/industry-news/pharma-execs-see-benefits-of-value-based-deals-but-remain-wary60%Hourly2017-09-25 14:33
https://www.healtheconomics.com/industry-news/value-based-contracting-an-uncertainty-for-pfizer60%Hourly2017-09-25 14:21
https://www.healtheconomics.com/books/new-book-how-economics-professors-can-stop-failing-us-the-discipline-at-a-crossroads60%Hourly2017-09-24 16:21
https://www.healtheconomics.com/government/gordon-gop-bill-will-destroy-medicaid60%Hourly2017-09-24 15:42
https://www.healtheconomics.com/government/fda-official-says-clinical-trials-system-is-broken60%Hourly2017-09-22 16:07
https://www.healtheconomics.com/health-reform/linthicum-value-goes-hand-in-hand-with-true-reform60%Hourly2017-09-22 15:44
https://www.healtheconomics.com/industry-news/precision-medicine-group-announces-new-set-of-services60%Hourly2017-09-22 15:16
https://www.healtheconomics.com/health-reform/forbes-contributor-slams-republican-health-effort60%Hourly2017-09-22 14:59
https://www.healtheconomics.com/government/health-care-industry-reacts-to-graham-cassidy-bill60%Hourly2017-09-22 14:30
https://www.healtheconomics.com/industry-news/looking-at-the-top-health-care-systems60%Hourly2017-09-21 16:39
https://www.healtheconomics.com/government/sanders-health-bill-contains-fallback-plan60%Hourly2017-09-21 16:21
https://www.healtheconomics.com/industry-news/opportunity-to-bolster-writing-abilities-nears60%Hourly2017-09-21 15:43
https://www.healtheconomics.com/industry-news/hedis-calendar-aims-to-keep-you-organized60%Hourly2017-09-21 15:28
https://www.healtheconomics.com/industry-news/inovalon-daiichi-sankyo-inc-to-back-outcomes-based-contracting60%Hourly2017-09-21 14:51
https://www.healtheconomics.com/government/cbo-says-it-wont-have-full-score-on-graham-cassidy-bill-before-vote60%Hourly2017-09-20 16:41
https://www.healtheconomics.com/industry-news/a-call-for-open-source-cost-effectiveness-analysis60%Hourly2017-09-20 16:27
https://www.healtheconomics.com/industry-news/ispor-announces-plenary-sessions-speakers-for-european-congress60%Hourly2017-09-20 16:14
https://www.healtheconomics.com/government/numerof-associates-co-founder-prepare-for-macra-now60%Hourly2017-09-20 15:46
https://www.healtheconomics.com/industry-news/maps-2018-issues-call-for-workshop-proposals60%Hourly2017-09-20 15:06
https://www.healtheconomics.com/industry-news/your-pick-for-the-best-health-care-system-in-the-world-is60%Hourly2017-09-19 19:29
https://www.healtheconomics.com/industry-news/cms-calls-for-innovative-pricing-models60%Hourly2017-09-19 18:52
https://www.healtheconomics.com/industry-news/amgen-wins-historic-fda-approval-takes-aim-at-3-billion-cancer-drug-avastin60%Hourly2017-09-19 20:04
https://www.healtheconomics.com/industry-news/does-your-doctor-make-house-calls60%Hourly2017-09-19 18:54
https://www.healtheconomics.com/industry-news/the-use-of-real-world-evidence-in-health-care-decision-making60%Hourly2017-09-18 19:44
https://www.healtheconomics.com/industry-news/the-meaning-and-measure-of-value-in-healthcare60%Hourly2017-09-18 18:27
https://www.healtheconomics.com/industry-news/cochrane-announces-new-membership-scheme-and-all-are-welcome60%Hourly2017-09-18 16:14
https://www.healtheconomics.com/industry-news/population-health-management-four-key-changes-managed-care-executives-should-be-watching60%Hourly2017-09-18 15:42
https://www.healtheconomics.com/industry-news/unitedhealthcare-selects-inovalon-one-platform60%Hourly2017-09-15 17:08
https://www.healtheconomics.com/government/fda-commissioner-targets-orphan-drug-loopholes60%Hourly2017-09-15 16:36
https://www.healtheconomics.com/industry-news/nonprofit-altarum-develops-value-based-insurance-model60%Hourly2017-09-15 16:04
https://www.healtheconomics.com/industry-news/discussing-causal-interference-rwe60%Hourly2017-09-15 15:37
https://www.healtheconomics.com/government/a-look-at-sen-sanders-health-bill60%Hourly2017-09-15 14:54
https://www.healtheconomics.com/industry-news/berger-to-lead-shyft-product-advisory-board60%Hourly2017-09-14 16:19
https://www.healtheconomics.com/government/dr-price-health-care-should-be-patient-centered60%Hourly2017-09-14 15:46
https://www.healtheconomics.com/comparative-effectiveness/icer-posts-draft-scoping-document-for-emicizumab-review60%Hourly2017-09-14 15:23
https://www.healtheconomics.com/health-reform/fee-for-service-remains-top-dog60%Hourly2017-09-14 15:11
https://www.healtheconomics.com/industry-news/groups-push-cms-to-revise-biosimilar-payment-policy60%Hourly2017-09-14 14:37
https://www.healtheconomics.com/industry-news/study-licensing-reimbursement-issues-create-inequity-in-cancer-treatment-access60%Hourly2017-09-13 19:13
https://www.healtheconomics.com/industry-news/phrmas-campbell-criticizes-jama-internal-medicine-study60%Hourly2017-09-13 16:22
https://www.healtheconomics.com/industry-news/icer-less-favorable-cost-effectiveness-for-amgens-evolocumab60%Hourly2017-09-13 15:56
https://www.healtheconomics.com/industry-news/g-trust-seeks-to-help-assess-clinical-guidelines-for-patient-outcomes60%Hourly2017-09-13 15:14
https://www.healtheconomics.com/industry-news/generating-rwe-for-both-regulators-and-payers60%Hourly2017-09-13 14:58
https://www.healtheconomics.com/industry-news/hollin-value-assessment-frameworks-should-represent-a-spectrum-of-patient-preferences60%Hourly2017-09-11 14:49
https://www.healtheconomics.com/industry-news/health-economist-public-should-have-role-in-drug-pricing60%Hourly2017-09-11 14:44
https://www.healtheconomics.com/government/report-big-pharma-company-helped-fuel-opioid-epidemic60%Hourly2017-09-11 00:18
https://www.healtheconomics.com/government/could-dacas-end-lead-to-public-health-crisis60%Hourly2017-09-11 00:08
https://www.healtheconomics.com/health-reform/medicaid-could-help-address-social-determinants-of-health60%Hourly2017-09-10 23:40
https://www.healtheconomics.com/industry-news/editorial-when-it-comes-to-the-drug-pricing-debate-talk-is-cheap60%Hourly2017-09-10 23:22
https://www.healtheconomics.com/government/california-senate-could-vote-on-drug-transparency-bill60%Hourly2017-09-08 16:24
https://www.healtheconomics.com/industry-news/the-journey-to-value60%Hourly2017-09-08 15:58
https://www.healtheconomics.com/industry-news/how-can-a-new-value-framework-impact-orphan-drug-woes60%Hourly2017-09-08 15:40
https://www.healtheconomics.com/industry-news/departing-novartis-ceo-eyes-silicon-valley-what-next60%Hourly2017-09-08 14:48
https://www.healtheconomics.com/industry-news/stat-report-ibm-watson-misses-mark-on-cancer60%Hourly2017-09-08 14:30
https://www.healtheconomics.com/industry-news/e2-group-president-talks-star-ratings-mtm60%Hourly2017-09-07 15:27
https://www.healtheconomics.com/industry-news/preparing-for-impact-understanding-macra60%Hourly2017-09-07 14:55
https://www.healtheconomics.com/industry-news/do-clinical-results-outweigh-cost60%Hourly2017-09-05 16:11
https://www.healtheconomics.com/industry-news/peeples-drake-to-speak-at-amwa-meeting-in-orlando60%Hourly2017-09-05 15:52
https://www.healtheconomics.com/industry-news/outcomes-measurement-in-the-modern-era-a-hospital-imperative60%Hourly2017-09-05 15:26
https://www.healtheconomics.com/industry-news/taking-a-look-at-novartis-breakthrough-cancer-drug60%Hourly2017-09-04 18:12
https://www.healtheconomics.com/industry-news/cancer-doctor-discusses-car-t-precision-medicine-and-pricing60%Hourly2017-09-04 17:33
https://www.healtheconomics.com/industry-news/steep-cuts-in-store-for-aca-advertising-budget60%Hourly2017-09-04 17:02
https://www.healtheconomics.com/government/kymriah-outcomes-based-arrangement-may-unleash-more-drug-pay-schemes-at-cms60%Hourly2017-09-04 15:22
https://www.healtheconomics.com/industry-news/helping-in-the-aftermath-of-harvey60%Hourly2017-09-01 17:10
https://www.healtheconomics.com/industry-news/gottlieb-targets-risk-info-in-drug-ads-on-tv60%Hourly2017-09-01 16:51
https://www.healtheconomics.com/industry-news/frenova-names-wallace-clinical-medical-operations-executive-director60%Hourly2017-09-01 16:23
https://www.healtheconomics.com/comparative-effectiveness/icer-inadequate-evidence-to-compare-parp-inhibitors-across-ovarian-cancer-indications60%Hourly2017-09-01 15:46